DeMichiei Robert 4

What Happened

• Robert DeMichiei, a director of Ardent Health, Inc. (ARDT), purchased 11,260 shares in open-market transactions on June 5, 2026. The Form 4 reports a weighted average price of $8.73 per share, for a total transaction value of roughly $98,300. This was a purchase (Transaction code P), which is an insider buy rather than a sale.

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-08 (filed within the required reporting window).
• Price: weighted average $8.73; trades occurred at prices ranging from $8.60 to $8.78 per share (footnote explains multiple transactions and offers to provide a per-price breakdown on request).
• Shares acquired: 11,260; total consideration: approx. $98,300.
• Shares owned after transaction: not specified in the provided filing excerpt—see the full Form 4 for post-transaction holdings.
• Footnote: F1 discloses the $8.73 weighted average and the price range $8.60–$8.78 and notes the reporting person can provide the number of shares bought at each price upon request.

Context

• Insider purchases can be more informative than sales because they represent a director adding to their stake; however, filings are factual records and do not state the insider’s motive. This was a straightforward open-market purchase (no options exercise, grant, or gift involved).